Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $2.31 USD
Change Today -0.0647 / -2.72%
Volume 3.9K
GNVC On Other Exchanges
Symbol
Exchange
NASDAQ CM
Frankfurt
As of 8:10 PM 07/30/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Kevin M. Rooney

Former Director and Member of Audit Committee, GenVec, Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 2 different industries.

49--

Background*

Mr. Kevin M. Rooney has been the President of Beacon Consulting Group since 2007. Mr. Rooney served as Vice President of Oncology Sales and Marketing at Medimmune Inc. since July 2005. In this position, Mr. Rooney was responsible for strategic oversight of the sales and marketing organization for MedImmune's marketed oncology product, Ethyol. Mr. Rooney served as MedImmune's Senior Director of Marketing at Synagis until July 2005. Prior to MedImmune in July 2003, Mr. ...

Read Full Background

Corporate Headquarters*

910 Clopper Road
Gaithersburg, Maryland 20878

United States

Phone: 240-632-0740
Fax: 240-632-0735

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

Bachelor's Degree
University of Virginia
Master's Degree
Northwestern University
Master's Degree
J.L. Kellogg School of Management, Northwestern University

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
GNVC:US $2.31 USD -0.0647

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Jeffrey D. Abbey MBA, J.D.Chief Executive Officer, President and Director
Argos Therapeutics, Inc.
$543.6K
Kalevi Reijonen M.D.Chief Executive Officer and President
FIT Biotech Oy
--
Hans Arwidsson Ph.D.Chief Executive Officer and President
Eurocine Vaccines AB
kr1.1M
Daniel J. O'Connor Esq.Chief Executive Officer, President and Director
Advaxis, Inc.
$398.8K
William D. Clark Chief Executive Officer, President and Director
Genocea Biosciences, Inc.
$393.6K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GENVEC INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.